Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Early stage prion assembly involves two subpopulations with different quaternary structures and a secondary templating pathway.

Igel-Egalon A, Laferrière F, Moudjou M, Bohl J, Mezache M, Knäpple T, Herzog L, Reine F, Jas-Duval C, Doumic M, Rezaei H, Béringue V.

Commun Biol. 2019 Oct 4;2:363. doi: 10.1038/s42003-019-0608-y. eCollection 2019.

PMID:
31602412
2.

Prion strain-dependent tropism is maintained between spleen and granuloma and relies on lymphofollicular structures.

Al-Dybiat I, Moudjou M, Martin D, Reine F, Herzog L, Truchet S, Berthon P, Laude H, Rezaei H, Andréoletti O, Béringue V, Sibille P.

Sci Rep. 2019 Oct 10;9(1):14656. doi: 10.1038/s41598-019-51084-1.

PMID:
31601984
3.

Thermostability as a highly dependent prion strain feature.

Marín-Moreno A, Aguilar-Calvo P, Moudjou M, Espinosa JC, Béringue V, Torres JM.

Sci Rep. 2019 Aug 6;9(1):11396. doi: 10.1038/s41598-019-47781-6.

4.

Heterogeneity and Architecture of Pathological Prion Protein Assemblies: Time to Revisit the Molecular Basis of the Prion Replication Process?

Igel-Egalon A, Bohl J, Moudjou M, Herzog L, Reine F, Rezaei H, Béringue V.

Viruses. 2019 May 10;11(5). pii: E429. doi: 10.3390/v11050429. Review.

5.

Pressure Reveals Unique Conformational Features in Prion Protein Fibril Diversity.

Torrent J, Martin D, Noinville S, Yin Y, Doumic M, Moudjou M, Béringue V, Rezaei H.

Sci Rep. 2019 Feb 26;9(1):2802. doi: 10.1038/s41598-019-39261-8.

6.

Correction to: In Vitro Seeding Activity of Glycoform-Deficient Prions from Variably Protease-Sensitive Prionopathy and Familial CJD Associated with PrPV180I Mutation.

Wang Z, Yuan J, Shen P, Abskharon R, Lang Y, Dang J, Adornato A, Xu L, Chen J, Feng J, Moudjou M, Kitamoto T, Lee HG, Kim YS, Langeveld J, Appleby B, Ma J, Kong Q, Petersen RB, Zou WQ, Cui L.

Mol Neurobiol. 2019 Aug;56(8):5470. doi: 10.1007/s12035-019-1508-3.

PMID:
30707392
7.

In Vitro Seeding Activity of Glycoform-Deficient Prions from Variably Protease-Sensitive Prionopathy and Familial CJD Associated with PrPV180I Mutation.

Wang Z, Yuan J, Shen P, Abskharon R, Lang Y, Dang J, Adornato A, Xu L, Chen J, Feng J, Moudjou M, Kitamoto T, Lee HG, Kim YS, Langeveld J, Appleby B, Ma J, Kong Q, Petersen RB, Zou WQ, Cui L.

Mol Neurobiol. 2019 Aug;56(8):5456-5469. doi: 10.1007/s12035-018-1459-0. Epub 2019 Jan 5. Erratum in: Mol Neurobiol. 2019 Feb 1;:.

8.

Reversible unfolding of infectious prion assemblies reveals the existence of an oligomeric elementary brick.

Igel-Egalon A, Moudjou M, Martin D, Busley A, Knäpple T, Herzog L, Reine F, Lepejova N, Richard CA, Béringue V, Rezaei H.

PLoS Pathog. 2017 Sep 7;13(9):e1006557. doi: 10.1371/journal.ppat.1006557. eCollection 2017 Sep.

9.

Corrigendum: A Universal Influenza Vaccine Can Lead to Disease Exacerbation or Viral Control Depending on Delivery Strategies.

Bernelin-Cottet C, Deloizy C, Stanek O, Barc C, Bouguyon E, Urien C, Boulesteix O, Pezant J, Richard CA, Moudjou M, Costa BD, Jouneau L, Chevalier C, Leclerc C, Sebo P, Bertho N, Schwartz-Cornil I.

Front Immunol. 2017 Jul 18;8:831. doi: 10.3389/fimmu.2017.00831. eCollection 2017.

10.

A stretch of residues within the protease-resistant core is not necessary for prion structure and infectivity.

Munoz-Montesino C, Sizun C, Moudjou M, Herzog L, Reine F, Igel-Egalon A, Barbereau C, Chapuis J, Ciric D, Laude H, Béringue V, Rezaei H, Dron M.

Prion. 2017 Jan 2;11(1):25-30. doi: 10.1080/19336896.2016.1274851. Epub 2017 Feb 8.

11.

A Universal Influenza Vaccine Can Lead to Disease Exacerbation or Viral Control Depending on Delivery Strategies.

Bernelin-Cottet C, Deloizy C, Stanek O, Barc C, Bouguyon E, Urien C, Boulesteix O, Pezant J, Richard CA, Moudjou M, Da Costa B, Jouneau L, Chevalier C, Leclerc C, Sebo P, Bertho N, Schwartz-Cornil I.

Front Immunol. 2016 Dec 26;7:641. doi: 10.3389/fimmu.2016.00641. eCollection 2016. Erratum in: Front Immunol. 2017 Jul 18;8:831.

12.

Glycoform-independent prion conversion by highly efficient, cell-based, protein misfolding cyclic amplification.

Moudjou M, Chapuis J, Mekrouti M, Reine F, Herzog L, Sibille P, Laude H, Vilette D, Andréoletti O, Rezaei H, Dron M, Béringue V.

Sci Rep. 2016 Jul 7;6:29116. doi: 10.1038/srep29116.

13.

Generating Bona Fide Mammalian Prions with Internal Deletions.

Munoz-Montesino C, Sizun C, Moudjou M, Herzog L, Reine F, Chapuis J, Ciric D, Igel-Egalon A, Laude H, Béringue V, Rezaei H, Dron M.

J Virol. 2016 Jul 11;90(15):6963-6975. doi: 10.1128/JVI.00555-16. Print 2016 Aug 1.

14.

Emergence of two prion subtypes in ovine PrP transgenic mice infected with human MM2-cortical Creutzfeldt-Jakob disease prions.

Chapuis J, Moudjou M, Reine F, Herzog L, Jaumain E, Chapuis C, Quadrio I, Boulliat J, Perret-Liaudet A, Dron M, Laude H, Rezaei H, Béringue V.

Acta Neuropathol Commun. 2016 Feb 5;4:10. doi: 10.1186/s40478-016-0284-9.

15.

Purification and Refolding to Amyloid Fibrils of (His)6-tagged Recombinant Shadoo Protein Expressed as Inclusion Bodies in E. coli.

Li Q, Richard CA, Moudjou M, Vidic J.

J Vis Exp. 2015 Dec 19;(106):e53432. doi: 10.3791/53432.

16.

Mutated but Not Deleted Ovine PrP(C) N-Terminal Polybasic Region Strongly Interferes with Prion Propagation in Transgenic Mice.

Khalifé M, Reine F, Paquet-Fifield S, Castille J, Herzog L, Vilotte M, Moudjou M, Moazami-Goudarzi K, Makhzami S, Passet B, Andréoletti O, Vilette D, Laude H, Béringue V, Vilotte JL.

J Virol. 2015 Nov 25;90(3):1638-46. doi: 10.1128/JVI.02805-15. Print 2016 Feb 1.

17.

C-Nap1 mutation affects centriole cohesion and is associated with a Seckel-like syndrome in cattle.

Floriot S, Vesque C, Rodriguez S, Bourgain-Guglielmetti F, Karaiskou A, Gautier M, Duchesne A, Barbey S, Fritz S, Vasilescu A, Bertaud M, Moudjou M, Halliez S, Cormier-Daire V, Hokayem JE, Nigg EA, Manciaux L, Guatteo R, Cesbron N, Toutirais G, Eggen A, Schneider-Maunoury S, Boichard D, Sobczak-Thépot J, Schibler L.

Nat Commun. 2015 Apr 23;6:6894. doi: 10.1038/ncomms7894.

18.

Interaction between Shadoo and PrP Affects the PrP-Folding Pathway.

Ciric D, Richard CA, Moudjou M, Chapuis J, Sibille P, Daude N, Westaway D, Adrover M, Béringue V, Martin D, Rezaei H.

J Virol. 2015 Jun;89(12):6287-93. doi: 10.1128/JVI.03429-14. Epub 2015 Apr 8.

19.

Identification and characterization of the binding site of the respiratory syncytial virus phosphoprotein to RNA-free nucleoprotein.

Galloux M, Gabiane G, Sourimant J, Richard CA, England P, Moudjou M, Aumont-Nicaise M, Fix J, Rameix-Welti MA, Eléouët JF.

J Virol. 2015 Apr;89(7):3484-96. doi: 10.1128/JVI.03666-14. Epub 2015 Jan 7.

20.

Preclinical detection of variant CJD and BSE prions in blood.

Lacroux C, Comoy E, Moudjou M, Perret-Liaudet A, Lugan S, Litaise C, Simmons H, Jas-Duval C, Lantier I, Béringue V, Groschup M, Fichet G, Costes P, Streichenberger N, Lantier F, Deslys JP, Vilette D, Andréoletti O.

PLoS Pathog. 2014 Jun 12;10(6):e1004202. doi: 10.1371/journal.ppat.1004202. eCollection 2014 Jun.

21.

Highly infectious prions generated by a single round of microplate-based protein misfolding cyclic amplification.

Moudjou M, Sibille P, Fichet G, Reine F, Chapuis J, Herzog L, Jaumain E, Laferrière F, Richard CA, Laude H, Andréoletti O, Rezaei H, Béringue V.

MBio. 2013 Dec 31;5(1):e00829-13. doi: 10.1128/mBio.00829-13.

22.

Quaternary structure of pathological prion protein as a determining factor of strain-specific prion replication dynamics.

Laferrière F, Tixador P, Moudjou M, Chapuis J, Sibille P, Herzog L, Reine F, Jaumain E, Laude H, Rezaei H, Béringue V.

PLoS Pathog. 2013;9(10):e1003702. doi: 10.1371/journal.ppat.1003702. Epub 2013 Oct 10.

23.

Shadoo binds lipid membranes and undergoes aggregation and fibrillization.

Li Q, Chevalier C, Henry C, Richard CA, Moudjou M, Vidic J.

Biochem Biophys Res Commun. 2013 Aug 30;438(3):519-25. doi: 10.1016/j.bbrc.2013.07.104. Epub 2013 Aug 1.

PMID:
23911790
24.

Plasminogen-based capture combined with amplification technology for the detection of PrP(TSE) in the pre-clinical phase of infection.

Segarra C, Bougard D, Moudjou M, Laude H, Béringue V, Coste J.

PLoS One. 2013 Jul 24;8(7):e69632. doi: 10.1371/journal.pone.0069632. Print 2013.

25.

Glycoform-selective prion formation in sporadic and familial forms of prion disease.

Xiao X, Yuan J, Haïk S, Cali I, Zhan Y, Moudjou M, Li B, Laplanche JL, Laude H, Langeveld J, Gambetti P, Kitamoto T, Kong Q, Brandel JP, Cobb BA, Petersen RB, Zou WQ.

PLoS One. 2013;8(3):e58786. doi: 10.1371/journal.pone.0058786. Epub 2013 Mar 19.

26.

Mammalian prions: tolerance to sequence changes-how far?

Salamat MK, Munoz-Montesino C, Moudjou M, Rezaei H, Laude H, Béringue V, Dron M.

Prion. 2013 Mar-Apr;7(2):131-5. doi: 10.4161/pri.23110. Epub 2012 Dec 11. Review.

27.

Nucleoprotein nanostructures combined with adjuvants adapted to the neonatal immune context: a candidate mucosal RSV vaccine.

Remot A, Roux X, Dubuquoy C, Fix J, Bouet S, Moudjou M, Eléouët JF, Riffault S, Petit-Camurdan A.

PLoS One. 2012;7(5):e37722. doi: 10.1371/journal.pone.0037722. Epub 2012 May 24.

28.

Integrity of helix 2-helix 3 domain of the PrP protein is not mandatory for prion replication.

Salamat K, Moudjou M, Chapuis J, Herzog L, Jaumain E, Béringue V, Rezaei H, Pastore A, Laude H, Dron M.

J Biol Chem. 2012 Jun 1;287(23):18953-64. doi: 10.1074/jbc.M112.341677. Epub 2012 Apr 16.

29.

Oligomerization paths of the nucleoprotein of influenza A virus.

Tarus B, Bakowiez O, Chenavas S, Duchemin L, Estrozi LF, Bourdieu C, Lejal N, Bernard J, Moudjou M, Chevalier C, Delmas B, Ruigrok RW, Di Primo C, Slama-Schwok A.

Biochimie. 2012 Mar;94(3):776-85. doi: 10.1016/j.biochi.2011.11.009. Epub 2011 Nov 29.

PMID:
22155087
30.

Characterization of spontaneously generated prion-like conformers in cultured cells.

Zou RS, Fujioka H, Guo JP, Xiao X, Shimoji M, Kong C, Chen C, Tasnadi M, Voma C, Yuan J, Moudjou M, Laude H, Petersen RB, Zou WQ.

Aging (Albany NY). 2011 Oct;3(10):968-84.

31.

PB1-F2 influenza A virus protein adopts a beta-sheet conformation and forms amyloid fibers in membrane environments.

Chevalier C, Al Bazzal A, Vidic J, Février V, Bourdieu C, Bouguyon E, Le Goffic R, Vautherot JF, Bernard J, Moudjou M, Noinville S, Chich JF, Da Costa B, Rezaei H, Delmas B.

J Biol Chem. 2010 Apr 23;285(17):13233-43. doi: 10.1074/jbc.M109.067710. Epub 2010 Feb 19.

32.

Endogenous proteolytic cleavage of disease-associated prion protein to produce C2 fragments is strongly cell- and tissue-dependent.

Dron M, Moudjou M, Chapuis J, Salamat MK, Bernard J, Cronier S, Langevin C, Laude H.

J Biol Chem. 2010 Apr 2;285(14):10252-64. doi: 10.1074/jbc.M109.083857. Epub 2010 Feb 12.

33.

The respiratory syncytial virus M2-1 protein forms tetramers and interacts with RNA and P in a competitive manner.

Tran TL, Castagné N, Dubosclard V, Noinville S, Koch E, Moudjou M, Henry C, Bernard J, Yeo RP, Eléouët JF.

J Virol. 2009 Jul;83(13):6363-74. doi: 10.1128/JVI.00335-09. Epub 2009 Apr 22.

34.

Glycan chains modulate prion protein binding to immobilized metal ions.

Moudjou M, Bernard J, Sabuncu E, Langevin C, Laude H.

Neurochem Int. 2007 Apr;50(5):689-95. Epub 2007 Jan 14.

PMID:
17293006
35.

Prion protein in the cerebrospinal fluid of healthy and naturally scrapie-affected sheep.

Picard-Hagen N, Gayrard V, Viguié C, Moudjou M, Imbs C, Toutain PL.

J Gen Virol. 2006 Dec;87(Pt 12):3723-7.

PMID:
17098990
36.

Prion proteins from susceptible and resistant sheep exhibit some distinct cell biological features.

Sabuncu E, Paquet S, Chapuis J, Moudjou M, Lai TL, Grassi J, Baron U, Laude H, Vilette D.

Biochem Biophys Res Commun. 2005 Nov 25;337(3):791-8. Epub 2005 Sep 28.

PMID:
16214113
37.

Glycan-controlled epitopes of prion protein include a major determinant of susceptibility to sheep scrapie.

Moudjou M, Treguer E, Rezaei H, Sabuncu E, Neuendorf E, Groschup MH, Grosclaude J, Laude H.

J Virol. 2004 Sep;78(17):9270-6. Erratum in: J Virol. 2004 Oct;78(20):11449. Neuendorf, Erdi [corrected to Neuendorf, Erdmute].

38.

Prion protein is secreted in soluble forms in the epididymal fluid and proteolytically processed and transported in seminal plasma.

Gatti JL, Métayer S, Moudjou M, Andréoletti O, Lantier F, Dacheux JL, Sarradin P.

Biol Reprod. 2002 Aug;67(2):393-400.

PMID:
12135872
39.

Cellular prion protein status in sheep: tissue-specific biochemical signatures.

Moudjou M, Frobert Y, Grassi J, La Bonnardière C.

J Gen Virol. 2001 Aug;82(Pt 8):2017-24.

PMID:
11458009
40.

Studying the composition and function of centrosomes in vertebrates.

Bornens M, Moudjou M.

Methods Cell Biol. 1999;61:13-34. Review. No abstract available.

PMID:
9891307
41.

Characterization of the human homologue of the yeast spc98p and its association with gamma-tubulin.

Tassin AM, Celati C, Moudjou M, Bornens M.

J Cell Biol. 1998 May 4;141(3):689-701.

42.

Glutamylation of centriole and cytoplasmic tubulin in proliferating non-neuronal cells.

Bobinnec Y, Moudjou M, Fouquet JP, Desbruyères E, Eddé B, Bornens M.

Cell Motil Cytoskeleton. 1998;39(3):223-32.

PMID:
9519903
43.

Most of centrin in animal cells is not centrosome-associated and centrosomal centrin is confined to the distal lumen of centrioles.

Paoletti A, Moudjou M, Paintrand M, Salisbury JL, Bornens M.

J Cell Sci. 1996 Dec;109 ( Pt 13):3089-102.

44.

gamma-Tubulin in mammalian cells: the centrosomal and the cytosolic forms.

Moudjou M, Bordes N, Paintrand M, Bornens M.

J Cell Sci. 1996 Apr;109 ( Pt 4):875-87.

45.

Molecular characterisation of ninein, a new coiled-coil protein of the centrosome.

Bouckson-Castaing V, Moudjou M, Ferguson DJ, Mucklow S, Belkaid Y, Milon G, Crocker PR.

J Cell Sci. 1996 Jan;109 ( Pt 1):179-90.

46.

The chk1 pathway is required to prevent mitosis following cell-cycle arrest at 'start'.

Carr AM, Moudjou M, Bentley NJ, Hagan IM.

Curr Biol. 1995 Oct 1;5(10):1179-90.

47.

Identification of an HSP70-related protein associated with the centrosome from dinoflagellates to human cells.

Perret E, Moudjou M, Geraud ML, Derancourt J, Soyer-Gobillard MO, Bornens M.

J Cell Sci. 1995 Feb;108 ( Pt 2):711-25.

48.

Antibodies that can discriminate between dynein heavy chains and their HUV1 photoproducts.

Sperling L, Houari A, Moudjou M, Mazarguil H, Wright M.

Cell Motil Cytoskeleton. 1994;29(3):271-9.

PMID:
7895291
49.

Centrosome organization and centriole architecture: their sensitivity to divalent cations.

Paintrand M, Moudjou M, Delacroix H, Bornens M.

J Struct Biol. 1992 Mar-Apr;108(2):107-28.

PMID:
1486002
50.

[Is the centrosome a dynamic structure?].

Moudjou M, Bornens M.

C R Acad Sci III. 1992;315(13):527-34. French.

PMID:
1300235

Supplemental Content

Loading ...
Support Center